3,4-Difluorotoluene | CAS:2927-34-6

We serve 3,4-Difluorotoluene CAS:2927-34-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3,4-Difluorotoluene

Product Name: 3,4-Difluorotoluene
Other Name: 1,2-Difluoro-4-methylbenzene;3,4-Difluoro methyl benzene;
CAS No: 2927-34-6
MF: C7H6F2
MW: 128.11900
Density: 1.12 g/mL at 25 °C(lit.)
Boiling point: 110-113 °C(lit.)
Flash point: 77 °F
Refractive index: n20/D 1.45(lit.)
Vapor Pressure: 26.7mmHg at 25°C
UN Number: UN1993
UN Proper Shipping Name: FLAMMABLE LIQUID, N.O.S.
Transport hazard class: 3
Packing group: III
 
Specification
Appearance: Colorless to light yellow transparent liquid
Purity: ≥98%
Water: ≤0.5%
 
Application: Organic intermediates, pharmaceutical intermediates, agrochemical intermediates.
Package: 25kg/drum, packed in plastic drum or plastic coated iron drum.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 3,4-Difluorotoluene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,4-Difluoro methyl benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-Difluorotoluene Use and application,3,4-Difluorotoluene technical grade,usp/ep/jp grade.


Related News: The quality of the drug substance determines the quality of the preparation, so its quality standards are very strict. Countries around the world have formulated strict national pharmacopoeia standards and quality control methods for their widely used drug substances.2-Bromopyridine-4-carboxylic acid manufacturer The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.2',3',5'-Tri-O-acetyl-D-adenosine supplier The chemical compound which is in the process of becoming an API from a raw material is called an intermediate.1-(2,5-dimethylthiophen-3-yl)ethanone vendor From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.